PATENT CLAIM ANALYSIS

Application Number: 16297115
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "210000"]

Abstract:
Indazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma RORγt are described. Pharmaceutical compositions including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described.

Claim (Index 7):
A pharmaceutical composition comprising at least one compound of formula (I) according to  claim 1 , a pharmaceutically acceptable salt thereof, a hydrate thereof and/or a solvate thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.44231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15537678', '15537580', '15537667', '15537591', '11029064']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.817501763650424
- 35 USC 102 Novelty (BERT): 0.5917742390825932
- Combined Prediction Score: 0.794929011193641
- Mean Citation Score: 456.877754
- Max Citation Score: 546.8221
- Similarity Product: 436.43869468265166

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test